The HIV response beyond 2030: preparing for decades of sustained HIV epidemic control in eastern and southern Africa
Adam Akullian(Institute for Disease Modeling), Joyce Ng'ang'a, Glenda Gray(South African Medical Research Council), Austin Carter(University of Washington), Solange Baptiste, Mbulawa Mugabe, Valentina Cambiano(University College London), Mohammed Abdulaziz(Centers for Disease Control and Prevention), Christophe Fraser(University of Oxford), Helen Ayles(University of London), Gesine Meyer‐Rath(University of the Witwatersrand), Jeffrey W. Eaton(Imperial College London), Nduku Kilonzo, Mpho Mmelesi, Edinah Mudimu(University of South Africa), Loveleen Bansi‐Matharu, Nafiisah Chotun, Eline L. Korenromp, Mary Mahy(Joint United Nations Programme on HIV/AIDS), Leigh F. Johnson(University of Cape Town), Peter Godfrey‐Faussett(London School of Hygiene & Tropical Medicine), Maurine Murenga, David Kaftan(New York University), Anna Bershteyn(New York University), Lucie Abeler‐Dörner, Alison P. Galvani(Yale University), Gambo Aliyu(National Agency for the Control of AIDS), M. Kate Grabowski(Johns Hopkins University), Joseph Kagaayi(Rakai Health Sciences Program), Haroon Moolla(University of Cape Town), Olanrewaju Edun, Edward Kataika, Daniel Citron(New York University), James Hargreaves(University of the Witwatersrand), Sikhulile Moyo(Harvard University), Rowan Martin‐Hughes(Burnet Institute), Wilford Kirungi, Anne-Claire Guichard, Robert Glabius, Sharmistha Mishra(St. Michael's Hospital), Ruth Akulu, Mach-Houd Kouton, Samuel Matsikure, Florence Anam, Rachel Baggaley(World Health Organization), Geoffrey P. Garnett, Michelle Morrison, Shona Dalal(World Health Organization), Siobhan Crowley, Tara D. Mangal(Imperial College London)
Cited by 10
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k